Title: The Secreted Serine Protease xHtrA1 Stimulates LongRange FGF Signaling in the Early Xenopus Embryo
1The Secreted Serine Protease xHtrA1 Stimulates
Long-Range FGF Signaling in the Early Xenopus
Embryo
- Shirui Hou,1,2 Marco Maccarana,3 Tan H. Min,2 Ina
Strate,1,2 and Edgar M. Pera1,2, 1 Department of
Developmental Biochemistry, Institute of
Biochemistry and Cell Biology, Georg August
University Go ttingen, 37077 Go ttingen,
Germany 2 Laboratory of Vertebrate Developmental
Biology, Lund Strategic Research Center for Stem
Cell Biology and Cell Therapy 3 Department of
Experimental Medical Science Lund University,
22184 Lund, Sweden Correspondence
edgar.pera_at_med.lu.se DOI 10.1016/j.devcel.2007.07.
001
2xHtrA1 encodes a Protease
- SP signal peptide
- Trypsin serine protease domain
- PDZ protein interaction zone
- IB insulin-like growth factor binding domain
- K kazal-type serine protease inhibitor domain
3Serine Protease
- Serine residue in active site
- Trypsin cleaves peptide bonds following positive
amino acid residues
4PDZ domain
- oligomeric proteins involved in heat-shock
response, chaperone function, and apoptosis. - Regulates protease activity
5xHtrA1 expression resembles FGF8
- unbiased screen for proteins in the early xenopus
embryos a cDNA clone of xHtrA1 was isolated - In Situ hybridization for xHtrA1 revealed similar
pattern to FGF8 expression
6Microinjection of xHtrA1
Stage 12
- xHtrA1 mRNA (made by RT-PCR from cDNA) was
injected into stage 12 embryos and observed at
later stages like stage 42, the swimming tadpole
stage
mRNA
7Injection of xHtrA1 induces secondary tail
structures
- When xHtrA1 mRNA was injected into xenopus early
stage embryos secondary tail structures developed
8Tail in the Tummy? GFP as a lineage marker
- Co-injection of xHtrA1 mRNA with GFP on the
dorsal side of the embryo, secondary tail-like
structures developed on the belly - Tail structures were devoid of GFP and
histologically complete
9Because the tail structures were devoid of GFP,
what can be said about xHtrA1?
- xHtrA1 is not a posteriorizing agent
- xHtrA1 is only important for head development
- xHtrA1 has inductive effects at a considerable
distance - A and B
- None of the above
10Trypsin mutants reveal the role of xHtrA1s
proteolytic domain
xHtrA1 (S307A) mutantcatalytic serine residue in
position 307 replaced with alanine
11Trypsin mutants have normal phenotypes
- wild-type xHtrA1 anencephaly and secondary tail
formation - xHtrA1?trypsin normal development
- xHtrA1 (S307A) normal development
- xHtrA1 ability to induce ectopic tails is
dependent upon a functional proteolytic domain
12The loss of the phenotype when mutant xHtrA1 was
injected can be attributed to
- Heparan sulfate could not be cleaved from cell
surface proteoglycans - FGF could not bind the mutant xHtrA1 protein
- The RTKs are not cleaved to induce long-term
signaling - Mutant xHtrA1 cannot travel through the ECM
- The proteoglycan core proteins could not be
cleaved
13Model
Cleavage of core proteins releases Heparan-FGF
complexes into ECM
14Review
- Injection with xHtrA1 causes loss of head
structure and ectopic tail growth
15xHtrA1-MO injection enlarged heads, reduced eye
size and shortened tails
- Injection of xHtrA1-MO had an opposite pheontype
from xHtrA1 injection
16The xHtrA1-MO revealed xHtrA1s roles as
- Restrictive function in head development
- Supportive role in tail outgrowth
- Head development enhancer
- All of the Above
- A and B
17Cooperation between FGF signals and xHtrA1
FGF4 xHtrA1
Uninjected
FGF4
xHtrA1
- FGF4 xHtrA1 dramatic elongation
- FGF4 alone mild mesoderm elongation
- xHtrA1 alone mild mesoderm elongation
18(No Transcript)
19ERK
- Must be diphosphorilated to be activated
- Mek phosphorilates both ser/thr and tyr on ERK
20Analyzing Activation of ERK
Hepes and protease inhibitor cocktail
Embryos were lysed and proteins were
extracted Separated on SDS Page gel Isolation of
ERK by immunoprecipitation Immunoblotting using
anti-dpERK
Stage 12 Embryo
SDS Page
Co-Ip
Western Blot using anti-dpERK
21xHtrA1 stimulates FGF signal intermediate
- Microinjection of xHtrA1 accumulation of
activated ERK - Microinjection of xHtrA1-MO blocked activation of
ERK
22Creation of Inducer Cap
Animal caps were injected with FGF4, xHtrA1, and
nlacZ
23Animal Caps can be Fused
Fusion of two animal caps
24nlacZ
- Stains nucleus
- Appears blue
- Used to show distinction between inducer and
responder cap
25xbra
- A.k.a. brachyury (T)
- Functions as switch between cell migration and
convergent extension - In the experiment, only used as a mesoderm marker
26Fusion of Inducer and Responder Caps
- Inducer fused with regular animal caps (responder
caps) - The caps were analyzed by in situ hybridization
for Xbra, a mesoderm marker
27xHtrA1 promotes long-term FGF signaling
- FGF4 weak effect
- xHtrA1 weak effect
- FGF4 xHtrA1 robust growth of responder cap
and greatly elevated Xbra levels far away from
sites of FGF4 secretion
28Proteoglycan side chains must be removed
- Occurs when proteoglycans are collected from
embryo - Side chains must be removed to get definite bands
29Use of Hek293 Cells
- Human Embryonic Kidney Cells transformed with
sheared adenoveirus 5 DNA - Harvested from an aborted fetus in late 70s
- Extreme transfectability
- In this experiment
- Transfected cDNA of each type of proeteoglycan
using calcium phosphate method - Cells were lysed and proteoglycans were isolated
by SDS Page - Result proteoglycans without heparan sulfate
chains
30xHtrA1 causes proteolytic degradation
- Western blot of xHtrA1 and flag tagged xbiglycan
and heparan sulfate proteoglycans, xsyndecan and
xglypican - Revealed that xHtrA1 degrades all three
proteoglycans
31Conclusion
xHtrA1 effectively cleaves core proteins from
three types of proteoglycans syndecan, glypican,
and biglycan